Serum Spexin as a Biomarker for Early Diabetic Nephropathy in Iraqi T2DM Patients: Correlation with Glycemic Indices and HOMA-β

Authors

  • Azhar Mohammed Brbber Ministry of Education, Al Muthanna Education Directorate, samawa city Iraq

Keywords:

Spexin, Type 2 diabetes mellitus, Diabetic nephropathy, HOMA-β, Triglyceride-glucose index, Biomarker, ROC curve analysis

Abstract

Aims/hypothesis Clinical studies revealed that serum spexin level is associated with Glycemic Indices and HOMA-IR. However, the role of spexin as a potential biomarker for the early detection of diabetic nephropathy in Iraqi patients with T2DM remains unclear. We hypothesise that spexin could correlation between circulating Spexin levels, glycemic control indices (HbA1c, FBG), and β-cell functional HOMA-β across different stages of kidney problems. This study aims to assess the existing and future biomarkers used to diagnose or predict early DN. Early detection of DN may lead to improvement in clinical management and quality of life, emphasizing the importance of identifying a specific and reliable predictive biomarker.

Methods A total of 90 subjects were recruited in this cross-sectional study, including 30 healthy subjects, 30 of type 2 diabetes mellitus (T2DM), 30 of established diabetic nephropathy DN. We measured anthropometric data, fasting serum glucose (FSG), glycated hemoglobin (HbA1c), lipid profile, fasting insulin, HOMA-IR, HOMA-β, the triglyceride-glucose (TyG) index, and serum Spexin. These were analyzed using one-way ANOVA with post-hoc pairwise testing, Pearson correlation, and receiver operating characteristic (ROC) curve analysis.

Results Serum Spexin levels were significantly lower in both T2DM (411.63 ± 82.23 ng/mL, p = 0.003) and DN (401.13 ± 87.11 ng/mL, p = 0.002) groups, compared with healthy subjects [505.30 ± 129.83 ng/ml (P-value 0.002)]. There was no significant difference between the two diabetic groups (p = 0.515). Spexin had a negative correlation with fasting Serum glucose (FSG) (r = − 0.303, P < 0.001), hemoglobin A1c (HbA1c) (r = − 0.278, P < 0.001), and TYG (r = − 0.268, P < 0.001), and WHR (r = − 0.240, P < 0.01), and positively correlated with HOMA-β (r = 0.255, P < 0.01) and HDL-C (r = 0.295, P < 0.001), ), but did not correlate with HOMA-IR. ROC analysis indicated acceptable differentiation of Spexin levels between controls and T2DM (AUC 0.726) and between controls and DN (AUC 0.736), but poor differentiation between T2DM and DN (AUC 0.549).

Conclusion: Serum Spexin levels significantly decrease with the onset of T2DM and remain low as nephropathy develops. This supports its role as an indicator of the diabetic metabolic state rather than a specific marker for kidney involvement. Its connections with blood sugar and lipid levels, but not with HOMA-IR, suggest a relationship with declining β-cell function rather than peripheral insulin resistance.

Downloads

Published

2026-11-15

Issue

Section

Articles

How to Cite

1.
Azhar Mohammed Brbber. Serum Spexin as a Biomarker for Early Diabetic Nephropathy in Iraqi T2DM Patients: Correlation with Glycemic Indices and HOMA-β. Sawa Med. J. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];2(4):835-49. Available from: https://smj.sawauniversity.edu.iq/article/view/899